ABVC BioPharma, Inc. Employee Stock Ownership Plan (ESOP), Compensation Expense
ABVC BioPharma, Inc. (ABVC) reported Employee Stock Ownership Plan (ESOP), Compensation Expense of $1.06 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense · last filed 2026-03-03
- ABVC BioPharma, Inc. employee stock ownership plan (esop), compensation expense for the quarter ending 2025-12-31 was $337.50K.
- ABVC BioPharma, Inc. employee stock ownership plan (esop), compensation expense for the quarter ending 2025-09-30 was $395.00K.
- ABVC BioPharma, Inc. employee stock ownership plan (esop), compensation expense for fiscal 2025 was $1.06M.
| Period end | Employee Stock Ownership Plan (ESOP), Compensation Expense 3 month | Employee Stock Ownership Plan (ESOP), Compensation Expense 6 month | Employee Stock Ownership Plan (ESOP), Compensation Expense 9 month | Employee Stock Ownership Plan (ESOP), Compensation Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $337.50K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $732.50K derived: sum of 2 quarters · filed 2026-03-03 | $1.06M 10-K · filed 2026-03-03 | |
| 2025-09-30 | $395.00K 10-Q/A · filed 2026-03-03 | $725.00K 10-Q/A · filed 2026-03-03 |